Home arrow Projects arrow Treatment arrow Immunotherapy arrow 3rd International Workshop on Structured Treatment Interruption

Announcements

  • HIV Forum congrulates Nina Mani on her new position at FDA
    • MAY-17-13 Please join the Forum in congratulating Nina Mani on an exciting new career move. Nina is leaving the Forum, but she is not going far – starting June 3 she will join the FDA Center for Drug Evaluation Research, Division of Antiviral Products. That we will miss her is the understatement of the century. But the offer to join our colleagues at the FDA as a project manager presented a phenomenal opportunity – an excellent fit for her career path. We congratulate Jeff, Kim, Jules and Patrick on an excellent choice! We imagine that many of you will have the pleasure of interacting with her in her new capacity.
  • National Viral Hepatitis Action Plan to Be Renewed

    • MAY-16-13 Dr. Howard Koh, the Assistant Secretary for Health, announced on May 16 that the partner agencies are committed and dedicated to renewing the Action Plan for another three years and are currently working on their vision and priorities for 2014-2016.

  • HIV Forum Mourns the Passing of Executive Committee Member Dr. Jim Goodrich
    • MAY-10-13 We are saddened to report the death of James Goodrich, PhD, MD of ViiV Healthcare, a member of the Forum’s Executive Committee. Jim passed away unexpectedly last weekend and is survived by his wife, Carolyn and two teenage daughters. A memorial service for Jim will be held this summer on a date to be determined. Jim has been a considered and thoughtful participant on the Executive Committee. His desire to improve care for patients, direct approach and sense of humor will be missed. Please join us in keeping Jim’s family in our thoughts and prayers.
  • New AIDS Publication: "Getting to normal: are we there yet?"

    • May-08-13 - Forum Executive Director Veronica Miller and Executive Committee Member Michael Horberg have co-authored an editorial comment, "Getting to normal: are we there yet?" in Volume 27, Issue 6 of AIDS.
    Click Here to Access the Article

  • Art Reingold apointed to Advisory Council on Immunization Practices
    • MAY-06-13 Arthur Reingold, MD, professor of epidemiology and associate dean for research at the UC Berkeley School of Public Health, was appointed to the Advisory Committee on Immunization Practices (ACIP) by Secretary Kathleen Sebelius of the Department of Health and Human Services. Learn more>>>

Join Our Email Service

Sign up to receive email updates from the Forum
 
3rd International Workshop on Structured Treatment Interruption

Follow up Roundtable Discussion: Recommendations for a Specific Research Agenda

Background:

The Forum was a co-sponsor of the 3rd International Workshop on Structured Treatment Interruptions, held on March 22-24, 2002 in Montreal, Canada. Other sponsors were: FAIR, Project Inform, TAG, and GMHC. Approximately 80 scientists and community advocates gathered to present and discuss new data and issues surrounding treatment interruptions used in various settings, focusing on specific issues surrounding treatment interruptions. The following topics were discussed: Therapeutic Immunization and Immune Modulation, Immune Escape, STI and Drug Resistance in Salvage Patients, STI and Drug Resistance in Virologically Suppressed Patients and Drug-Sparing Strategies and Toxicity Reduction.

The Forum sponsored a follow-up smaller Roundtable to discuss and recommend a specific research agenda for treatment interruptions.

Objectives:

The Roundtable discussion focused on three topics:

  • Analytic uses of STI's in the development of immune-based treatments and/or strategies,
  • Drug sparing strategies,
  • Patients with multi-drug resistant virus.

Three questions were posed for each topic: What research gaps exist and which questions need answering? What collaborations, new initiatives or other activities are necessary for this agenda to move forward? What funding mechanisms neet to be put into place for the agenda to move forward?

Status

The full workshop report will be posted on the Forum's and other sponsor's websites shortly. A report of the follow-up Roundtable is currently being prepared.

Project Specific Sponsoring: The STI Workshop in Montreal was sponsored by Abbott Laboratories, Agouron, Bristol-Myers Squibb, Forum for Collaborative HIV Research, Gilead Pharmaceuticals, GlaxoSmithKline, Roche Pharmaceuticals, Treatment Action Group, ViroLogic.
A grant from Chiron Corporation funded the follow-up Roundtable.